LESLIE BARNETT: Open Payments
NPI 1003427907 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 34 payments from 9 companies in 2025. Trend: 2023 $458 · 2024 $2,560 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $163 |
| Ipsen Biopharmaceuticals, Inc | 9 | $156 |
| Madrigal Pharmaceuticals | 9 | $152 |
| Intra-Sana Laboratories | 3 | $67 |
| Mirum Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| ORPHALAN INC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: MAVYRET, IQIRVO, REZDIFFRA, RELTONE 200 MG, Livmarli, Wegovy, CUVRIOR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
